Variant report
Variant | nsv974252 |
---|---|
Chromosome Location | chr13:69541155-69546026 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531478036 | chr13:69541158-69541159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541726447 | chr13:69541160-69541161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561508146 | chr13:69541218-69541219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527487870 | chr13:69541225-69541226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532523290 | chr13:69541237-69541238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115453703 | chr13:69541257-69541258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566831116 | chr13:69541270-69541271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551008078 | chr13:69541309-69541310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532675858 | chr13:69541337-69541338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144095228 | chr13:69541345-69541346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs59978700 | chr13:69541497-69541498 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199991286 | chr13:69541516-69541517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs67281366 | chr13:69541517-69541518 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569276505 | chr13:69541520-69541521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs538499251 | chr13:69541525-69541526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151306120 | chr13:69541528-69541529 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147840396 | chr13:69541529-69541530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141748447 | chr13:69541530-69541531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555292046 | chr13:69541563-69541564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1541199 | chr13:69541608-69541609 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs534108350 | chr13:69541616-69541617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554376572 | chr13:69541641-69541642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12861761 | chr13:69541659-69541660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530320481 | chr13:69541663-69541664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12861765 | chr13:69541665-69541666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576827684 | chr13:69541687-69541688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545513022 | chr13:69541692-69541693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181785699 | chr13:69541750-69541751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146529682 | chr13:69541776-69541777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1541198 | chr13:69541797-69541798 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs201037349 | chr13:69541811-69541812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147058946 | chr13:69541812-69541813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201822052 | chr13:69541815-69541816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377507212 | chr13:69541818-69541819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141099427 | chr13:69541851-69541852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1541197 | chr13:69541871-69541872 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs540852292 | chr13:69541927-69541928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369948395 | chr13:69541964-69541965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs76794225 | chr13:69541972-69541973 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532472838 | chr13:69541977-69541978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186808254 | chr13:69541981-69541982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111987235 | chr13:69542031-69542032 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73518002 | chr13:69542052-69542053 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs34663360 | chr13:69542079-69542080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs34437818 | chr13:69542080-69542081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs148786692 | chr13:69542081-69542082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35199061 | chr13:69542082-69542083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147123059 | chr13:69542090-69542091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369883285 | chr13:69542101-69542102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111364604 | chr13:69542102-69542103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 22737080 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:69540800-69541200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr13:69541200-69541600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr13:69541400-69542400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr13:69541600-69541800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr13:69541600-69543400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr13:69541800-69542000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr13:69541800-69542400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr13:69541800-69542400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr13:69541800-69544000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr13:69542000-69543800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr13:69542400-69543800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr13:69542400-69543800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
13 | chr13:69543800-69545400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr13:69543800-69545600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr13:69543800-69545800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr13:69543800-69546200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr13:69543800-69546400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr13:69544000-69545800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr13:69544000-69546000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
20 | chr13:69544200-69545600 | Enhancers | H1 Cell Line | embryonic stem cell |
21 | chr13:69544200-69545800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
22 | chr13:69545400-69547400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |